Chemically engineered PLGA nanospheres are one of the emerging technologies for treating neurodegenerative disorders by inhibiting Catechol-O-methyltransferase (COMT). PLGA-MATPM nanospheres were chemically synthesized using PLGA and MATPM (N-allyl-N-(3-(m-tolyloxy)propyl) methioninate). The tailored PLGA nanospheres induce dose-dependent COMT inhibition in competitive kinetic mode. The interactions between COMT and PLGA nanosphere are explained by spectroscopic and molecular dynamics analysis. PLGA-MATPM NPs suppressed the growth of neuroblastoma cells due to the neurodegenerative toxicity of MPTP induction, demonstrating its potency as a cure for neurological disorders. PLGA-MATPM NPs cross the blood-brain barrier more effectively than those in the blood. Furthermore, PLGA nanospheres showed the most neurodegenerative recovery against MPTP-induced C57BL/6 mice. Using magnetic resonance imaging (MRI), it was validated for quality images of cerebral blood flow (CBF).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioorg.2023.106673DOI Listing

Publication Analysis

Top Keywords

plga nanospheres
12
engineered plga
8
plga nanosphere
8
plga-matpm nps
8
plga
6
synthesis characterization
4
characterization chemical
4
chemical engineered
4
nanosphere triggering
4
triggering mechanism
4

Similar Publications

Dexamethasone Acetate-Loaded PLGA Nanospheres Targeting Liver Macrophages.

Macromol Biosci

November 2024

Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, Hradec Kralove, 50005, Czech Republic.

Glucocorticoids are potent anti-inflammatory drugs, although their use is associated with severe side effects. Loading glucocorticoids into suitable nanocarriers can significantly reduce these undesirable effects. Macrophages play a crucial role in inflammation, making them strategic targets for glucocorticoid-loaded nanocarriers.

View Article and Find Full Text PDF

Nanofibrous 3D scaffolds capable of individually controlled BMP and FGF release for the regulation of bone regeneration.

Acta Biomater

December 2024

Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor, MI 48109, USA; Macromolecular Science and Engineering Center, University of Michigan, Ann Arbor, MI 48109, USA; Department of Materials Science and Engineering, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

The current clinical applications of bone morphogenetic proteins (BMPs) are limited to only a few specific indications. Locally controlled delivery of combinations of growth factors can be a promising strategy to improve BMP-based bone repair. However, the success of this approach requires the development of an effective release system and the correct choice of growth factors capable of enhancing BMP activity.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the use of poly-lactic-co-glycolic acid (PLGA) and chitosan (CS) as delivery systems for a ribosome protein (TgRPS2) to create potential vaccines against a harmful zoonotic disease affecting humans and animals.
  • Researchers synthesized TgRPS2-PLGA and TgRPS2-CS nanospheres using novel techniques and evaluated their efficacy and toxicity before immunizing mice to assess immune responses.
  • Results indicated that the nanospheres effectively stimulated immune responses, increased specific immune cell populations, and inhibited pathogen replication in affected tissues, suggesting their potential as preventive agents against toxoplasmosis.
View Article and Find Full Text PDF
Article Synopsis
  • Osteoporosis presents a major health issue characterized by weakened bones, and traditional treatments often have undesirable side effects.
  • This study introduces a new treatment method using europium-doped superparamagnetic iron oxide nanocrystals encapsulated in PLGA to promote bone health by altering immune cell behavior and supporting bone-building cells.
  • In experiments with lab rats, these nanospheres were shown to effectively reduce bone loss by improving bone cell functions and targeting bone areas using magnetic guidance, significantly enhancing osteoporosis management.
View Article and Find Full Text PDF

Objective: The lipid-lowering simvastatin (SIM) has been shown to be an effective inhibitor of keloid proliferation. However, due to its low water solubility and short half-life, simvastatin aggregates to the liver and does not reach the skin lesions after oral administration, which restricts its widespread clinical use. The development of nanomedicine provides the possibility for us to break through this bottleneck problem clinically.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!